The title of this paper implies several problems. 1) Do biochemical changes occur during the expression of emotion? Is any of them characteristic of a specific affective change? 2) Do drugs which alter affect also alter the biochemical parameters? 3) Do individuals of similar behavioural pattern exhibit the same types of biochemical pattern? Although these questions are meaningless for the highly evolved Martians described by Wells in the paragraph quoted above, they are of the essence for those who wish to apply biochemical knowledge to the solution of the abiding problems of Earthmen.
Let us make a start by summarizing what is known about the biochemical changes in emotional and related states. A brief summary is given in Table I . Where the term "stress" has been used, investigators in this work have generally meant it to include those acute situations giving rise to a marked change of affect. The roster of changes is quite impressive, but many of them are non-specific or are at present related with difficulty to the activity of the nervous system. This is true for serum cholesterol, which is said to be elevated under both acute and chronic conditions of psychological stress; it is also the case with the reported change in the blood glutathione concentration and in the hippuric acid test. __The increases in the blood sugar and 'Allan Memorial Institute of Psychiatry and McGill University, Montreal, Associate Professor of Biochemistry, Department of Psychiatry.
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in the non-esterified fatty acids (NEFA) of the plasma are both manifestations of sympathoadrenal activity which, as is well known, increases in the so-called "emergency states" described by W. B. Cannon. There is little more to develop in research upon the reflex rise in the blood sugar under these conditions, except to verify the time relations between the elevation of the blood sugar and the rise in catecholamine. It is presumably an increase in adrenaline which evokes the hyperglycemia, for noradrenaline has much lower glycogenolytic activity. In regard to the plasma NEFA, it should be of great interest to determine whether the component fatty acids of this fraction are similar in analysis to the NEFA of resting plasma or whether they have a characteristic spectrum (in terms of chain length and degree of saturation) corresponding to the fatty acid composition of one or another organ (skin, liver, kidney, visceral adipose tissue, etc.). Such analyses are now feasible, using the technique of gas chromatography and may contribute very usefully to the study of the biochemistry and physiology of emotional states. For example, it is conceivable that different types of emotion might instigate the breakdown of fat in different areas of the body where the spectra of lipid components vary.
The increase in adrenal cortical activity, which has been well documented for such conditions as emotional disturbances, experimentally induced anxiety, competition in the sports arena, and anticipation of major surgery, may stem from the stimulus given by the sympathoadrenal system, or through central pathways passing through the hypothalamus to the hypophysis. Not only does the adrenal cortex register greater activity, but it appears to become more sensitive to cor- ticotropin, at least in the psychoneuroses and anxiety states. One of the great developments in the biochemistry of mental diseases has come from the growth of neuroendocrinology and, in particular, the study of the sympathoadrenal system. This is feasible now because of the availability of chemical and physical methods for the direct determination of the neurohumoral products of that system in the plasma and urine. Indeed, one of these methods was specifically developed in connection with research on mental diseases and was first applied (in Weil-Malherbe;s laboratory) to the study of the pathophysiology and the treatment of these diseases.
To what extent does the sympathoadrenal system contribute to the quality of affect? For many years there have been theories of one kind or another assigning a role to the autonomic nervous system in the manifestation or modification of behaviour. Overt behaviour was analyzed in order to classify humans as vagotonic or sympathotonic in type. The complexity and number of human behaviour types, however, has stood in the way of acceptance of these views. When the neurohumoral product of the sympathoadrenal nervous system was found, fifteen years ago, to include not only adrenaline but also noradrenaline, a second dimension became available for the construction of an autonomic theory of human behaviour and emotion. The dominant product of this effort was the theory of Funkenstein. According to Funkenstein, Greenblatt and Solomon ( 11, 12) some individuals secrete, in cer-tain life-situations, predominantly an adrenaline-like substance into the bloodstream others show a predominant secretion of noradenaline in similar circumstances. The two groups, according to these investigators, are differentiated by the vascular response to methacholine, a stable compound with acetylcholine-like activity. In one group there is a prolonged fall in blood pressure (lasting more than 25 minutes); in the other the hypotension is rapidly compensated, with a return to normal pressures. Funkenstein has suggested that methacholine first exerts its peripheral vasodilatory activity and then induces, through a central mechanism, the excessive secretion of either adrenaline or noradrenaline, depending upon the constitutional characteristics of the subjects. Funkenstein states that the patients with the prolonged depression in the blood pressure curve after methacholine tend to improve with electroshock therapy, in marked contradistinction to the high proportion of failures using this treatment upon the second group, i.e., those whose central component of the sympathetic nervous system is already functioning at a high level.
This hypothesis has been extended as a physiological basis not only for the two types of methacholine reactors, but also for two types of emotional expression. According to the argument, individuals who express their anger "inwards", that is to say, who express emotion passively, are adrenaline-secretors, whereas those who turn their emotion "outwards", those who for example demonstrate their anger in an active fashion with an aggresive display, are said to be noradenaline secretors. Elmadjian and his colleagues have investigated this aspect of catecholamine metabolism in a number of situations generally falling into the category of emotion-provoking stresses: normal persons in anticipatory states; persons operating a control panel simulating that of an airplane (the "pursuitmeter test"); contestants in professional and in amateur sports. Their interpretation of the data is that "active aggressive emotional displays are related to increased excretion of noradenaline, whereas tense, anxious, but passive emotional displays are related to increased excretion of adrenaline in association with a normal excretion of noradrenaline" (8) .
In spite of these findings and interpretations, the hypothesis that human beings can be characterized by their catecholamines is as yet unproved. Regan and Reilly have measured the changes in the plasma catecholamines, which would be expected to respond to central changes more quickly and sensitively than the urinary output. Their attempts to relate the plasma noradrenaline and adrenaline to various emotional states have thus far been unsuccessful (18) . Elmadjian (7) has claimed partial confirmation for the "Funkenstein test" in the results of some studies in which urinary catecholamines were measured, but a survey of the literature of the "Funkenstein test" shows that its significance is still indefinite (9) .
In a study of acutely ill patients admitted to our Institute for treatment, Drs. Curtis and Cleghorn (6) found that those exhibiting predominantly depression tended to excrete a somewhat greater amount of noradrenaline than the normal control subjects did. Those exhibiting anxiety mainly showed an elevated excretion of 17-hydroxycorticosteroids. Cases of agitated depression showed an increased excretion of both corticoids and adrenaline. Although this study dealt with a small group of patients (a total of 37) and excluded persons with the severest retarded depressions, the results suggest that affective states of differing quality do not lead to a uniform reactionpattern, but are characterized by different patterns of hormone excretion. This finding indicates that affective states have specific physiological concomitants, distinguishing one type of "psychic stress" from the others. Another fact which must be taken into account in attempting to relate catecholamine metabolism to affect or overt behaviour is the high degree of correlation between the rate of excretion of adrenaline and noradrenaline in psychiatric and healthy subjects, in professional hockey players, in surgical patients postoperatively, and in women undergoing normal labour and delivery (see [6] for references). In the study at this Institute, the correlation coefficient was 0.50, with little probability that this was due to chance factors. In the other reports this coefficient was 0.48-0.55. In other words the sympathoadrenal system of normal persons and those under physical or "psychic" stress tends to act as a unit, so that an increase in its activity is reflected generally in an increase in the excretion of both neurohumors. On the other hand, the value of r = 0.50 indicates that there is much room remaining for the operation of additional determining factors. These are the factors which psychiatric research ought to seek.
There is an argument current to the effect that because the urinary catecholamines represent only a few percent of the total amount of these substances turned over normally in the body, there can be little significance attached to this fraction, and that the a-methylated derivatives of the catecholamines should be preferentially measured if a correct picture of sympathoadrenal activity is to be obtained. Indeed, this view was presented even before there were methods for measuring the a-methylated metabolites. It is necessary to keep in mind, however, that the secretion and excretion of catecholamines fluctuates with physiological state and measurement of their rate of excretion can reveal additional aspects of these states. Furthermore, under certain conditions the free amines appear in the urine in grossly abnormal amounts. This is the case in electroshock therapy (22) and insulin sub-coma therapy (24) , when the excretion of adrenaline (but not noradrenaline) rises sharply. Even the "normal" rate of excretion of catecholamines by patients undergoing electroshock therapy has some predictive value for the ultimate outcome of treatment (21, 23) .
Many other studies in which the free urinary catecholamines have been measured have contributed very useful information in psychiatry, neurology, surgery, and various branches of internal medicine, not to speak of much work in physiology and pharmacology. Because the urinary catecholamines are a product of a portion of the nervous system -and they are readily sampled for laboratory determination -they will undoubtedly continue for some time as a subject of research interest for the neurochemist.
Earlier I raised the question of the relation between the effects of drugs on behaviour and their effects upon the biochemistry of the individual. I want to deal with but one aspect of the action of recent drugs which have proven useful in psychiatry, and that is the specificity of the above relationship. If we take the case of reserpine, it is known that the administration of large doses of reserpine to experimental animals causes the loss of cerebral amines, which may remain low in concentration for a long time, paralleling the sedation and other behavioural effects caused by the drug. Although the phenothiazines have somewhat similar indications and pharmacological actions, their administration does not lead to this decrease in brain amines, There is a similar example to be drawn from the group of drugs causing elevation of mood. Some, like iproniazid and tranylcypromine cause a prolonged inhibition of monoamine oxidase; others, like imipramine, have no effect upon this enzyme. Inhibition of monoamine oxidase has become widely used as a means of screening for anti-depressive agents, but of the many inhibitors only a few have proved to be useful. Although the extensive inhibition of this enzyme in pharmacological experiments with animals may lead to an increase in cerebral amines, the specific biochemical mechanism in man, where much lower doses are used, remains to be elucidated. It is important to keep in mind that iproniazid, the first of the MAO inhibitors (with activity in vivo) to be used clinically, has inhibitory action upon several other enzymes also, but we do not know if these have any role to play in the depressive process. Thus, we have some very important leads from biochemical pharmacology on the relation of behavioural effects and biochemical change; we still require new dataperhaps new techniques-to establish these findings in man.
Resume
On traite ici des elements connus touchant al'affectivite, elements que l'on considere, par hypothese, comme etant les facteurs: a) des modifications biochimiques apparaissant au cours de l'expression des emotions et de leur rapport possible avec des changements affectifs specifiques, b) de l'effet sur les elements des produits qui influencent les affects; c) d'un type de comportement similaire preserite par des individus dont les tableaux biochimiques sont semblables.
On relate les etudes poussees effectuees sur les manifestations neuro-endocriniennes sympathico-adrenaliennes et sur la catecholamine. Y est egalement exposee la signification de la secretion d'adrenaline et de noradrenaline provoquee par la methacholine dans certaines circonstances de la vie ainsi que son action sur les caracteres physiques du sujet, Bien qu'il ne soit pas preuve que l'etre humain puisse etre caracterise par ses catecholamines, il existe neanmoins une relation hypothCtique entre l'action biochimique des deux types de reaction ala methacholine et les deux types d'emotion, soit: 1) les secreteurs adrenaliens (coleres passives); 2) les secreteurs noradrenaliens (colere exteriorisee).
Une etude recente portant sur un contingent de trente-sept malades a revele un accroissement de la secretion de noradrenaline, par rapport aux niveaux de controle, chez les patients apredominance depressive. Chez ceux qui souffraient d'etats d'angoisse on observa une augmentation des 17-hydroxycorticosteroides et, dans les cas de depression agitante, des corticosteroides et de I'adrenaline, Les resultats conduisent apenser qu'il existe: a) un schema de la secretion hormonale different suivant les differents types d'etats affectifs; b) des concomitants physiologiques specifiques, differenciant les types de stress psychiques; c) que le systeme sympatho-adrenal des personnes normales et de celles qui subissent un stress physique ou psychique a ten dance areagir de facon similaire; un accroissement de l'activite reflete generalement une augmentation de la secretion des deux humeurs neurales, La specificite de Ia relation existant entre Ies effets de drogues recentes sur Ie comportement et leurs effets sur la biochimie de l'individu a ete utile ala psychiatrie. La pharmacologie biochimique nous a fourni des indices importants sur Ia relation existant entre les effets du comportement et la transformation biochimique. Des exemples sont illustres par les effets bien connus de la reserpine, de l'iproniazide et de la tranylcypromine.
